News about Drug Discovery & Development

The Jackson Laboratory and AbTherx to Boost Therapeutic Antibody Discovery

The Jackson Laboratory (JAX) has forged a strategic partnership with AbTherx to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.

Drug Discovery & Development | 13/05/2024 | By Aishwarya |  528

Ribobay Pharma Offers oligo CRDMO Services with Cytiva FlexFactory Platform

Ribobay Pharma has announced that it will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.

Drug Discovery & Development | 13/05/2024 | By Aishwarya |  409

OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)

The Vertex HFN offers an innovative approach to fracture fixation, aiming to enhance patient outcomes and streamline surgical procedures.

Drug Discovery & Development | 10/05/2024 | By Manvi |  452

Sanofi Signs Co-Exclusive Licensing Deal with Novavax to Co-Commercialize COVID-19 Vaccine

Sanofi has signed a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US.

Drug Discovery & Development | 10/05/2024 | By Aishwarya |  334

Zydus Completes Enrolment for EPICS IIITM Phase 2b/3 Trial of Saroglitazar Mg

Zydus Lifesciences has completed enrolment of Phase 2b/3 EPICS IIITM trial of Saroglitazar Mg in patients with Primary Biliary Cholangitis (PBC).

Drug Discovery & Development | 10/05/2024 | By Aishwarya |  517

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce Ventricular Pulsed Field Ablation Technology

The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythm

Drug Discovery & Development | 09/05/2024 | By Manvi |  412

BioVersys Extends its Strategic Collaboration with GSK

BioVersys has extended its strategic collaboration with the global biopharma company GSK to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of tuberculosis (TB).

Drug Discovery & Development | 09/05/2024 | By Aishwarya |  664

Anixa Biosciences Signs JDA with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types

The vaccines focus on a novel scientific mechanism never used before in a cancer vaccine.

Drug Discovery & Development | 08/05/2024 | By Manvi |  355

Selvita Acquires PozLab to Expand its Drug Development Capabilities

Selvita has completed a strategic transaction in which it has acquired 100% of shares in PozLab.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  460

ARTBIO and Nucleus to Manufacture GMP-Grade Therapeutic Products

ARTBIO, Inc. has announced a strategic manufacturing and supply agreement with Nucleus RadioPharma Inc. to support ARTBIO’s therapeutic product manufacturing.

Drug Discovery & Development | 08/05/2024 | By Aishwarya |  395